Product Pipeline

Our pipeline currently includes nine product candidates being developed by us and our majority-owned subsidiaries, Incuron, LLC and Panacela Labs, Inc., primarily focused on oncology and orphan applications.

CBLI Pipeline

Product	Research	Pre-clinical	Ph I	Pivotal	BLA
Entolimod (Protectan CBLB502)  Radiation Countermeasure
Product	Research	Pre-clinical	Ph I	Ph II	Ph III
Entolimod (Protectan CBLB502)  Advanced Solid Tumors
Protectan CBLB612  Bone Marrow Transplant (stem cell transplantation)

Incuron Pipeline

Product	Research	Pre-clinical	Ph I	Ph II	Ph III
Curaxin CBL0102  Advanced Solid Tumors
Curaxin CBL0137  Advanced Solid Tumors (oral)
Curaxin CBL0137  Advanced Solid Tumors (IV)

Panacela Pipeline

Product	Research	Pre-clinical	Ph I	Ph II	Ph III
Revercom  Chemo Adjuvant
Mobilan  Targeted Cancer Therapy
Arkil  Androgen Receptor Inhibitor
Antimycon  Cancer Therapeutic
Xenomycins  Anti-Infectives